Ameriprise Financial Inc Kiniksa Pharmaceuticals, Ltd. Transaction History

Ameriprise Financial Inc

$381 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$17.63 - $21.74 $847,192 - $1.04 Million	-48,054 Reduced 29.07%	117,231 $2.31 Million
Q4 2023 Feb 14, 2024	SELL	$14.37 - $19.07 $2.61 Million - $3.46 Million	-181,582 Reduced 52.35%	165,285 $2.9 Million
Q3 2023 Nov 14, 2023	SELL	$13.62 - $20.2 $332,436 - $493,041	-24,408 Reduced 6.57%	346,867 $6.03 Million
Q2 2023 Aug 14, 2023	SELL	$10.44 - $16.48 $2,474 - $3,905	-237 Reduced 0.06%	371,275 $5.23 Million
Q1 2023 May 15, 2023	BUY	$10.7 - $15.79 $159,387 - $235,207	14,896 Added 4.18%	371,512 $4 Million
Q4 2022 Feb 14, 2023	SELL	$11.42 - $17.05 $198,411 - $296,226	-17,374 Reduced 4.65%	356,616 $5.34 Million
Q3 2022 Nov 14, 2022	BUY	$9.76 - $13.41 $3.65 Million - $5.02 Million	373,990 New	373,990 $4.8 Million
Q2 2021 Aug 16, 2021	SELL	$13.22 - $19.09 $18.1 Million - $26.2 Million	-1,371,430 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$16.68 - $23.97 $16.7 Million - $24 Million	-999,806 Reduced 42.16%	1,371,430 $25.4 Million
Q4 2020 Feb 12, 2021	BUY	$14.8 - $21.15 $3.49 Million - $4.99 Million	235,977 Added 11.05%	2,371,236 $41.9 Million
Q3 2020 Nov 16, 2020	BUY	$15.21 - $25.53 $9.83 Million - $16.5 Million	646,420 Added 43.42%	2,135,259 $32.7 Million
Q2 2020 Aug 14, 2020	BUY	$15.08 - $26.0 $12.6 Million - $21.8 Million	837,770 Added 128.68%	1,488,839 $37.9 Million
Q1 2020 May 15, 2020	SELL	$11.0 - $19.76 $5.48 Million - $9.85 Million	-498,509 Reduced 43.36%	651,069 $10.1 Million
Q4 2019 Feb 14, 2020	BUY	$5.24 - $12.96 $2.5 Million - $6.19 Million	477,940 Added 71.16%	1,149,578 $12.7 Million
Q3 2019 Nov 14, 2019	SELL	$8.15 - $15.88 $606,131 - $1.18 Million	-74,372 Reduced 9.97%	671,638 $5.72 Million
Q2 2019 Aug 14, 2019	BUY	$13.2 - $20.39 $2.79 Million - $4.31 Million	211,385 Added 39.54%	746,010 $10.1 Million
Q1 2019 May 15, 2019	BUY	$15.93 - $26.59 $3.7 Million - $6.17 Million	231,985 Added 76.65%	534,625 $9.66 Million
Q4 2018 Feb 14, 2019	SELL	$16.25 - $28.09 $1.09 Million - $1.88 Million	-67,042 Reduced 18.14%	302,640 $8.5 Million
Q3 2018 Nov 14, 2018	SELL	$13.23 - $30.93 $4.67 Million - $10.9 Million	-352,609 Reduced 48.82%	369,682 $9.43 Million
Q2 2018 Aug 14, 2018	BUY	$16.73 - $20.35 $12.1 Million - $14.7 Million	722,291 New	722,291 $12.5 Million

Others Institutions Holding KNSA

# of Institutions

Shares Held

1.95M

Call Options Held

Put Options Held

Pictet Asset Management Sa Geneva 73, V8

1.52M
Shares

$30.2 Million
0.03% of portfolio
Spearhead Capital Advisors, LLC Wellington, FL

203K
Shares

$4.04 Million
2.82% of portfolio
Harbor Capital Advisors, Inc.

98.1K
Shares

$1.95 Million
0.08% of portfolio
Putnam Investments LLC Boston, MA

39.5K
Shares

$786,955
0.0% of portfolio
Birchview Capital, LP Burlington, VT

30K
Shares

$597,900
0.69% of portfolio

View Full List

About Kiniksa Pharmaceuticals, Ltd.

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $687M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

More about KNSA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account